Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial

Overview of attention for article published in Trials, December 2019

Altmetric Badge

Mentioned by

blogs: 1 blog

twitter: 2 X users

Citations

dimensions_citation: 54 Dimensions

Readers on

mendeley: 105 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,470 followers.

RT @DrAbdulRazak_MD: @Dr_Hari_Krishna @neo_twiter @JAMAPediatrics @EBNEO @ravimpatelmd @nicupodcast Surrogate outcome difference are not al…

Reply Repost Favourite

@Dr_Hari_Krishna @neo_twiter @JAMAPediatrics @EBNEO @ravimpatelmd @nicupodcast Surrogate outcome difference are not always clinically translatable which is why a trial powering clinical outcomes is important On the flip side, we have no solid evidence de

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.